Table 3 Crude odds ratio for impacts of perceived importance for HIV cure among MSM (N = 356)

Age group

 16–29

1.00

1.00

1.00

1.00

1.00

1.00

1.00

 30–39

0.85 (0.48–1.48)

0.65 (0.36–1.15)

1.18 (0.56–2.48)

1.21 (0.64–2.30)

0.58 (0.33–1.02)

0.60 (0.34–1.06)

1.80 (0.97–3.35)

 40–49

1.46 (0.80–2.66)

0.68 (0.36–1.27)

0.83 (0.35–1.96)

1.39 (0.70–2.76)

0.54 (0.29-1.00)*

0.90 (0.48–1.71)

0.98 (0.48–2.02)

 50 or over

1.27 0.69–2.35)

0.98 (0.51–1.89)

0.69 (0.28–1.74)

1.74 (0.88–3.45)

0.50 (0.27–0.94)*

0.23 (0.12–0.43)***

1.07 (0.52–2.21)

Education level

 Secondary or below

1.00

1.00

1.00

1.00

1.00

1.00

1.00

 Post-secondary or above

1.51 (0.96–2.38)

1.01 (0.64–1.60)

0.61 (0.34–1.11)

1.70 (1.00-2.9)

1.75 (1.09–2.81)*

0.65 (0.41–1.02)

1.73 (1.00-2.97)*

  STI history in the past year

1.16 (0.73–1.85)

0.76 (0.47–1.23)

1.24 (0.66–2.33)

1.33 (0.80–2.22)

1.22 (0.76–1.95)

1.44 (0.89–2.32)

0.90 (0.52–1.54)

Sexual activity after HIV diagnosis

1.07 (0.69–1.64)

0.30 (0.19–0.50)***

0.95 (0.52–1.75)

1.85 (1.11–3.08)*

0.94 (0.61–1.46)

0.86 (0.56–1.33)

1.55 (0.93–2.58)

  Engagement in chemsex

1.03 (0.67–1.58)

0.71 (0.46–1.11)

0.88 (0.48–1.64)

0.95 (0.58–1.54)

1.24 (0.80–1.91)

1.05 (0.68–1.62)

0.90 (0.55–1.46)

CD4 cell count (cells/uL)

 ≥ 500

1.00

1.00

1.00

1.00

1.00

1.00

1.00

 < 500

0.79 (0.52–1.20)

3.49 (2.20–5.52)***

0.78 (0.43–1.41)

0.54 (0.33–0.87)*

1.24 (0.81–1.89)

1.04 (0.68–1.58)

1.05 (0.65–1.68)

About Functional cure

 Anticipation

2.15 (1.38–3.36)***

1.56 (1.00-2.43)

0.87 (0.48–1.58)

1.08 (0.66–1.76)

1.34 (0.86–2.08)

0.61 (0.39–0.94)*

0.96 (0.59–1.58)

 Awareness

1.04 (0.68–1.60)

0.60 (0.39–0.93)*

1.19 (0.66–2.16)

1.01 (0.63–1.63)

0.85 (0.55–1.31)

0.73 (0.48–1.12)

1.31 (0.81–2.11)

 Willingness

0.68 (0.30–1.51)

2.10 (0.94–4.70)

0.97 (0.32–2.92)

1.01 (0.41–2.49)

1.87 (0.77–4.58)

2.20 (0.97-5.00)

0.79 (0.33–1.88)